Alteration of ADCC-related genes as a novel predictor of efficacy of cetuximab (cet)-based chemotherapy in patients (pts) with metastic colorectal cancer (mCRC)
Sunakawa, Y., et al. Alteration of ADCC-related genes as a novel predictor of efficacy of cetuximab (cet)-based chemotherapy in patients (pts) with metastic colorectal cancer (mCRC). J Clin Oncol. 2016 Jul;34(Suppl 4S):A589.